SONN — Sonnet Biotherapeutics Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Sonnet Biotherapeutics Holdings, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.501	7.35	27.6	3.05	2.27
Net Total Accounts Receivable
Net Total Receivables	0.132	—	—	—	0.787
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.17	7.64	28.8	5.41	4.74
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.3	0.274	0.182	0.303	0.227
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	31.5	7.99	29	5.83	5.43
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.1	4.72	6.7	8.16	5.52
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	35.1	4.97	6.73	8.37	5.66
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-3.61	3.02	22.3	-2.54	-0.226
Total Liabilities & Shareholders' Equity	31.5	7.99	29	5.83	5.43
Total Common Shares Outstanding